Your browser doesn't support javascript.
loading
Level of hepatitis B surface antigen might serve as a new marker to predict hepatocellular carcinoma recurrence following curative resection in patients with low viral load.
Zhou, Hua-Bang; Li, Qiao-Mei; Zhong, Zheng-Rong; Hu, Jing-Yi; Jiang, Xiao-Lan; Wang, Hao; Wang, Hui; Yang, Bing; Hu, He-Ping.
Afiliação
  • Zhou HB; Department of Hepatobiliary I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University Shanghai, China.
  • Li QM; Department of Hepatobiliary I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University Shanghai, China.
  • Zhong ZR; Department of Laboratory, First Affiliated Hospital, Bengbu Medical College Anhui, China.
  • Hu JY; Department of Digestive Diseases, Huashan Hospital, Fudan University Shanghai, China.
  • Jiang XL; Department of Hepatobiliary I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University Shanghai, China.
  • Wang H; Department of Hepatobiliary I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University Shanghai, China.
  • Wang H; Department of Hepatobiliary I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University Shanghai, China.
  • Yang B; Department of Hepatobiliary I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University Shanghai, China.
  • Hu HP; Department of Hepatobiliary I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University Shanghai, China.
Am J Cancer Res ; 5(2): 756-71, 2015.
Article em En | MEDLINE | ID: mdl-25973313

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article